In conclusion, our results revealed an upregulation in Circ‐ELP3 and, in contrast, a downregulation in Circ‐FAF1 in serum specimens of patients with breast cancer while the levels of these circRNAs showed a decrease and an increase values after treatment, respectively. Here, ELP3 is linked to breast cancer.